APPENDICES. A systematic review and economic model of the ...

Study Intervention Participants Outcomes
Core symptoms
CBCL parent rated
Teacher report form
Inclusion criteria
Diagnosis of ADHD
Reference
Tervo et al., 2002 93
Co-existent problems
Not reported
Diagnostic criteria
DSM-IV
Arm 1
Placebo
Twice daily for 6 days
(Individual administering medication
not reported)
Source
Updated search
Educational performance
Not reported
Number
Total randomised = 41 (male/female split not reported)
Total withdrawals unclear
Arm 2
MPH
0.05 mg/kg twice daily for 6 days
(Individual administering medication
not reported)
Setting
USA
Psychological function
Not reported
The authors described withdrawals, but did not present them separately
for children with and without ADHD-MD
Design
Crossover trial
Depression or anxiety
Not reported
Age
10 years (mean); 2.86 years (SD)
Quality of life
Not reported
Arm 3
MPH
0.3 mg/kg twice daily for 6 days
(Individual administering medication
not reported)
Duration
Total treatment period:
3 weeks (6 days per
treatment arm followed
by a 1-day washout
period)
Adverse events
Not reported
IQ
Not reported
Co-morbid disorders
Children with ADHD-MD were also included in the review, but data are
not extracted here
Additional outcomes
Not reported
Diagnostic subtypes
Not reported
© Queen’s Printer and Controller of HMSO 2006. All rights reserved.
Additional information
No relevant information reported
Purpose
To evaluate the
medication
responsiveness of
children with ADHD
(with or without motor
dysfunction). Only data
for children without
motor dysfunction
(ADHD-MD) have been
extracted
Health Technology Assessment 2006; Vol. 10: No. 23
351